Series 2: FDA Modernization Act of 1997 (FDAMA) — Section 112

Congress recognized that for some rare diseases, one well-designed trial may be all that’s feasible.

Laws exists to prevent impossible demands from erasing the only chance patients have to learn whether a treatment helps